IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1280
Positioning
Market Dominance
Manufacturing
Measuring And Control Equipment
$132.4B
Rainer M. Blair
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics.
Headcount
81.0K
HQ Base
Washington, District Of Columbia
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Dates updated upon official exchange announcement.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = DHR ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$DHR DANAHER CORP /DE/ | 55 | 52 | 63 | 48 | 45.8x | 39.8x | 6.3% | 4.0% | 59.3% | 17.6% | 13.8% | 5.4% | 0.7% | 33.0x | $132.4B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
DANAHER CORP /DE/ (DHR) receives a "Hold" rating with a composite score of 54.9/100. It ranks #1280 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Rainer M. Blair
Chief Executive Officer
Labor Force
81,000
52
46
83
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for DHR
In-line with peers — no strong momentum signal
Trading at a discount to fundamentals — favorable entry valuation
Average quality profile
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for DHR.
View All RatingsEarnings well-supported by fundamental cash flows
Material decline in asset turnover efficiency detected
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 52 | 38 | +14ALPHA |
| MOMENTUM | 48 | 35 | +13ALPHA |
| VALUATION | 63 | 49 | +14ALPHA |
| INVESTMENT | 46 | 85 | -39DRAG |
| STABILITY | 83 | 86 | -3NEUTRAL |
| SHORT INT | 76 | 87 | -11DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 6.4% vs WACC 8.8% (spread -2.4%)
GM 59% vs sector 43%, OM 18% vs sector 1%
Capital turnover 0.39x, R&D intensity 6.5%
Rev growth 5%, 10yr history
Interest coverage 17.2x, Net debt/EBITDA 13.3x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns DANAHER CORP /DE/ a Hold rating, with a composite score of 54.9/100 and 3 out of 5 stars. Ranked #1280 of 7,333 stocks, DHR presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 52/100, DHR shows adequate but unremarkable business quality. The company reports a return on equity of 6.3% (sector avg: -2.5%), gross margins of 59.3% (sector avg: 42.5%), net margins of 13.8% (sector avg: -0.2%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
DHR's value score of 63/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 45.78x, an EV/EBITDA of 39.79x, a P/B ratio of 2.90x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
With an investment score of 46/100, DHR exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of 5.4% vs. a sector average of 5.9% and a return on assets of 4.0% (sector: -0.1%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
DHR is currently showing below-average momentum at 48/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth stands at 5.4% year-over-year, while a beta of 0.95 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
DHR shows good financial stability with a score of 83/100. Key stability metrics include a beta of 0.95 and a debt-to-equity ratio of 33.00x (sector avg: 0.2x). This suggests manageable leverage and moderate price volatility, making it appropriate for investors seeking a balance between growth potential and capital preservation.
DHR carries a short interest score of 76/100, indicating moderate short selling activity. This is a neutral reading — not enough to signal systemic bearishness, but worth monitoring. Specific risk factors include elevated leverage (D/E: 33.00x). At $132.4B market cap (large-cap), DANAHER CORP /DE/ offers reasonable institutional liquidity.
DHR offers a modest dividend yield of 0.7%. While the income contribution is relatively small, even a small dividend signals management's commitment to shareholder returns and can serve as a signal of financial discipline.
DANAHER CORP /DE/ is a large-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #1280 of 7,333 overall (83rd percentile). Key comparisons include ROE of 6.3% exceeding the -2.5% sector median and operating margins of 17.6% above the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While DHR currently exhibits a HOLD profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Investment (46) is the limiting factor — improvement here would lift the composite score most.
EV/EBITDA 247% ABOVE SECTOR MEDIAN
ROE 355% BELOW SECTOR MEDIAN
Gross Margin 40% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF SEP 26, 2025 (Q2 FY2025)
We rate DANAHER CORP /DE/ (DHR) as a Hold with a composite score of 54.9/100 at a current price of $209.20. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in stability (83th percentile) and value (63th percentile), which together account for the majority of the composite score. All factors score above the 40th percentile, indicating no material weakness in the quantitative profile. We assign a Narrow Moat rating (49/100), Low uncertainty, and Poor capital allocation.
Key items to watch: quarterly earnings execution and sector-level competitive dynamics. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
DANAHER CORP /DE/ holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 54.9/100 places it at rank #1280 in our full 7,333-stock universe. With a $132.4B market capitalization, DANAHER CORP /DE/ operates at meaningful scale within the Manufacturing sector, providing competitive advantages in distribution, procurement, and customer reach.
Revenue is growing at 5%, though momentum at the 48th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 59% (+16.8pp vs sector) narrow to operating margins of 18% (+16.4pp vs sector) and net margins of 13.8%, yielding a gross-to-net conversion rate of 23%. This conversion rate is typical for the sector, suggesting a standard cost structure without notable efficiency advantages or disadvantages.
At a current price of $209.20, DANAHER CORP /DE/ is trading near fair value based on current fundamentals. Our value factor score of 63/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at a P/E of 45.8x (a 106% premium to the sector median of 22.3x), EV/EBITDA of 39.8x (at a premium), P/B of 2.9x, P/S of 6.3x. The above-sector P/E multiple suggests the market is pricing in superior growth or quality, which our analysis finds only partially justified by current fundamentals.
Gross margins of 59% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
A P/E of 45.8x leaves little room for execution misses — any earnings disappointment could trigger a sharp multiple compression.
Elevated short interest (76th percentile) indicates that sophisticated market participants are betting against the stock.
We assign a Low uncertainty rating to DANAHER CORP /DE/. The company exhibits strong financial stability with a beta of 0.95, conservative leverage (33% D/E), and a stability factor in the 83th percentile. The predictable nature of the business model and solid financial position reduce the range of potential outcomes, giving us confidence in our fair value estimate.
Specific risk factors that inform our assessment include: elevated valuation multiple (P/E 45.8x) that leaves limited margin for error. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 83th percentile and quality factor at the 52th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 59% provide a buffer against cost pressures; above-average stability (83th percentile) suggests predictable business dynamics; large-cap scale ($132.4B) provides resilience. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate DANAHER CORP /DE/'s capital allocation as Poor. Key concerns include suboptimal returns on capital. Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — DANAHER CORP /DE/ significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, DANAHER CORP /DE/ receives a Hold rating with a composite score of 54.9/100 (rank #1280 of 7,333). Our quantitative framework assigns a Narrow Moat (49/100, trend: stable), Low uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 59/100.
Our analysis supports a neutral stance on DANAHER CORP /DE/. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We assign DANAHER CORP /DE/ a Narrow Moat rating with a composite moat score of 49/100. The ROIC-WACC spread of -2.4% is the primary signal of economic value creation. The company possesses identifiable competitive advantages, though they are less entrenched than those of wide-moat peers. Our analysis indicates that DANAHER CORP /DE/ can sustain above-average returns on invested capital for at least 10 years, with the strongest contributor being margin superiority at 17.6/20.
The strongest moat sources are margin superiority (17.6/20) and financial resilience (10.5/20). GM 59% vs sector 43%, OM 18% vs sector 1%. Interest coverage 17.2x, Net debt/EBITDA 13.3x. These pillars form the core of DANAHER CORP /DE/'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (2.3/20) and economic value creation (8.8/20). Capital turnover 0.39x, R&D intensity 6.5%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect DANAHER CORP /DE/'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 59% providing a solid profitability foundation, operating margins of 18% reflecting effective cost management, moderate revenue growth of 5%. The margin cascade from 59% gross to 18% operating to 13.8% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality is adequate though not exceptional, with the quality factor at the 52th percentile.
The margin profile shows gross margins of 59%, operating margins of 18%, net margins of 13.8%. Return metrics include ROE of 6.3% and ROA of 4.0%. Relative to the Manufacturing sector, gross margins are 16.8 percentage points above the sector median of 43%, and ROE of 6.3% compares to a sector median of -2.5%.
The balance sheet reflects moderate leverage with D/E of 33%, a dividend yield of 0.67%, revenue growth of 5%. The sector median D/E is 0%, putting DANAHER CORP /DE/ at higher leverage than the typical peer. The combination of low leverage and healthy profitability provides significant financial resilience and strategic optionality.
Above 50MA
37.18%
Net New Highs
+51081

Jacobson & Schmitt Advisors increased its FirstService stake by 49,829 shares for $8.11 million in Q4, bringing total holdings to 144,994 shares (3.8% of portfolio). Despite shares lagging the S&P 500 by 25 percentage points over the past year, the fund sees value in FirstService's stable, recurring revenue model. Q3 results showed 4% revenue growth and 8% EPS growth, with solid fundamentals and low capital intensity supporting the investment thesis.
On February 17, Danaher Corporation (NYSE:DHR) announced an agreement to acquire Masimo Corporation (NASDAQ:MASI) for nearly $9.9 billion.
Danaher Corporation has agreed to acquire Masimo Corporation, positioning Masimo as a standalone business within Danaher's Diagnostics segment. The transaction has been unanimously approved by both companies' boards. Masimo trades on the NasdaqGS under the ticker NasdaqGS:MASI, with a recent share price of $175.25. For you as an investor, this deal connects Masimo, a med tech player, with a large industry buyer that intends to keep it as a focused diagnostics business. The stock has...
Danaher (NYSE:DHR) has entered a definitive agreement to acquire health tech firm Masimo. The deal will bring Masimo into Danaher as a standalone operating unit within its diagnostics-focused portfolio. The transaction is positioned as a material move for Danaher’s presence in patient monitoring and clinical diagnostics. For you as an investor, this deal sits at the intersection of medical technology and diagnostics, two areas that continue to attract attention from large healthcare groups...

Major M&A activity continues across multiple sectors: Starboard Value pushes TripAdvisor toward a sale, Hims & Hers acquires Eucalyptus for $1.15B to expand internationally, Danaher buys Masimo for $9.9B, Mister Car Wash goes private via Leonard Green for $3.1B, and Devon Energy completes a $21.4B merger with Coterra Energy. Meanwhile, Saks Global struggles with vendor shipments during bankruptcy, and Warner Bros. Discovery rejects Paramount's hostile bid.